RenstromA. Wilbur and Orville Wright: a reissue of a chronology commemorating the Hundredth Anniversary of the birth of Orville Wright, 1871. New York: Knopf, 1987.
2.
SiedenburgJ: The actual development of European aviation safety requirements in aviation medicine: prospects of future EASA requirements. Hippokratia, 2009; 13:106–109.
3.
UK Civil Aviation Authority and Medical Department: Diabetes Certification Guidance 03/2013 v2.0. www.caa.co.uk/docs/49/20130226DiabetesCertificationGuidanceFeb13.pdf (accessed April3, 2018).
4.
AlmekinderE: Can you be a pilot with diabetes?. https://www.thediabetescouncil.com/can-you-be-a-pilot-with-diabetes (accessed August14, 2016).
5.
MitchellSJ, HineJ, VeningJ, et al.: A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraft. Lancet Diabetes Endocrinol, 2017; 5:677–679.
6.
American Diabetes Association: Standards of Medical Care in Diabetes-2018. Diabetes Care, 2018; 41(Suppl 1):S55–S64.
7.
HerzogRI, SherwinRS: Diabetes: can tight glycemic control in diabetes benefit cognition?. Nat Rev Neurol, 2012:8; 124–126.
PoolsupN, SuksomboonN, KyawAM: Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr, 2013; 5:39–52.
10.
HeinemannL, FreckmannG, EhrmannD, et al.: Benefits of continuous glucose monitoring use in adults with type 1 diabetes and impaired hypoglycaemia awareness and/or severe hypoglycaemia treated with multiple daily insulin injections: results of the multi-centre, randomised controlled HypoDE study. Lancet, 2018: https://doi.org/10.1016/S0140-6736(18)30297-6.
11.
BeckR, RiddlesworthTD, RuedyKJ, et al.: Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol, 2017; 5:700–708.
12.
LindM, PolonskyW, HirschIB, et al.: Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections. The GOLD Randomized Clinical Trial. JAMA, 2017; 317:379–387.
13.
CongetI, BattelinoT, GiménezM, et al.: The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther, 2011; 13:49–54.
14.
MesserLH, ForlenzaGP, SherrJL, et al.: Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care, 2018; 41:789–796.
